BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Drug Development

  TauRx Therapeutics Release: Phase 3 Clinical Trial Begins in Early Form of Dementia

  September 10, 2012

   · 

  5 min read
• Business

  CMC Biologics Announces Mark W. Sawicki as Vice President, Global Business Development

  September 10, 2012

   · 

  3 min read
• Deals

  Biogen Idec, Inc. (Massachusetts) Sells BENLYSTA Royalty Rights to DRI Capital Managed Fund

  September 10, 2012

   · 

  1 min read
• Drug Development

  Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial

  September 10, 2012

   · 

  4 min read
• Genetown

  Charles River Laboratories (Massachusetts) to Present at Morgan Stanley Healthcare Conference

  September 10, 2012

   · 

  1 min read
• Business

  Osmotica Pharmaceutical Announces the Appointment of Darren Alkins as Executive Vice President

  September 10, 2012

   · 

  1 min read
• Business

  Illumina, Inc. Names Paul Bianchi as Senior Vice President of Human Resources

  September 10, 2012

   · 

  1 min read
• Business

  Sirtex Medical Announces Record U.S. Earnings of $59 Million for Fiscal Year 2012

  September 10, 2012

   · 

  1 min read
• Pharm Country

  FluoroPharma Diagnostic Imaging Products Included at Two Major Scientific Forums

  September 10, 2012

   · 

  4 min read
• Pharm Country

  Johnson & Johnson Symposium Honors 2012 Recipients of the Dr. Paul Janssen Award for Biomedical Research

  September 10, 2012

   · 

  6 min read